Description
Oseltamivir Phosphate Capsules (75 mg)
Healthy Inc is a specialized global supplier and exporter of advanced antiviral, respiratory, and critical-care infectious disease therapeutics. We provide ultra-high-purity, kinetically stable Oseltamivir Phosphate Hard Gelatin Capsules (75 mg), manufactured in WHO–GMP certified, high-capacity dedicated antiviral isolation facilities. This “Neuraminidase Inhibitor” is a massive-volume, high-priority export to infectious disease NGOs, hospital networks, and government health ministries in LATAM, the Middle East, Africa, and Southeast Asia, serving as the globally mandated, life-saving intervention for seasonal Influenza A and B, and a critical asset for national pandemic preparedness stockpiles.
Product Overview
This formulation contains Oseltamivir (as Oseltamivir Phosphate), a targeted prodrug that fundamentally halts the spread of the influenza virus within the respiratory tract, drastically reducing the severity and duration of the flu, and preventing fatal pneumonia complications.
The “Pandemic Defense & Viral Arrest” Specialist:
- Mechanism (The Neuraminidase Blockade): When the influenza virus infects a lung cell, it replicates and creates thousands of new viruses. To escape the host cell and infect neighboring cells, the virus relies on an enzyme called neuraminidase to snip its tether. Oseltamivir acts as a chemical lock, aggressively binding to and neutralizing this enzyme. The newly formed viruses remain permanently stuck to the dying host cell, completely halting the systemic spread of the infection.
- The 48-Hour Clinical Window: For Oseltamivir to be highly effective as a treatment, it must be initiated within 48 hours of the first onset of flu symptoms. Because it stops viral replication rather than killing existing viruses, intervening before the viral load peaks is clinically critical.
- The National Stockpile Advantage: Beyond standard seasonal flu treatment, Oseltamivir is heavily procured by government defense and health ministries in massive bulk quantities to stockpile against potential avian (H5N1) or swine flu pandemics, making this a highly lucrative B2B tender item.
Product Composition & Strength
We supply this product as a Precision-Blended Hard Gelatin Capsule, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the hygroscopic phosphate salt.
| Active Ingredient | Strength | Primary Clinical Function |
|---|---|---|
| Oseltamivir Phosphate USP/Ph.Eur. | 75 mg (Equivalent to Oseltamivir free base) | Global Standard: Target adult dose for rapid treatment and prophylaxis of Influenza A/B. |
| Excipients | Pregelatinized Starch / Croscarmellose Sodium / Povidone / Sodium Stearyl Fumarate | Diluent / Superdisintegrant (Engineered for immediate gastric capsule rupture and rapid systemic absorption) |
*Pack Sizes: 1×10 Blisters (Optimized perfectly for the standard 5-day acute treatment regimen of two capsules daily).
Technical & Logistics Specifications
Critical data for Pharmaceutical Importers, NGO Procurement Boards, and Government Tender Authorities.
| HS Code | 3004.90.99 (Medicaments containing other active substances – Antivirals) |
| CAS Number | 204255-11-8 (Oseltamivir Phosphate) |
| Dosage Form | Hard Gelatin Capsule (Immediate Release) |
| Packaging | High-Density Alu-PVC or Alu-Alu Blisters. Oseltamivir Phosphate is sensitive to environmental humidity. Secure blister packaging guarantees chemical stability and full therapeutic potency across Zone IVb tropical climates and prolonged stockpiling durations. |
| Storage | Store strictly below 25°C in a dry place. Protect from moisture. |
| Certificates | WHO-GMP, COPP, Free Sale Certificate |
Manufacturing Authority
Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.
- High-Capacity Antiviral Encapsulation: During global influenza outbreaks, the demand for Oseltamivir skyrockets overnight. Our facilities utilize strictly dedicated antiviral blocks equipped with ultra-high-speed automatic encapsulation machines. This guarantees that Healthy Inc can fulfill massive, emergency government tenders rapidly without risking cross-contamination with other drug classes.
Therapeutic Indications (Human Use)
Indicated for the targeted eradication of respiratory influenza viruses:
- Treatment of Influenza: Acute, uncomplicated illness due to influenza A and B infection in patients who have been symptomatic for no more than 48 hours.
- Prophylaxis of Influenza: Prevention of influenza in adults and adolescents following close contact with an infected individual, or during a community outbreak.
- CRITICAL CLINICAL NOTE: Oseltamivir is NOT a substitute for the annual influenza vaccination. It does not provide long-term immunity.
Dosage & Administration
Recommended Dosage (Strictly as per Physician/Health Ministry Guidelines):
- Standard Adult Treatment: 75 mg taken twice daily (every 12 hours) for exactly 5 days.
- Standard Adult Prophylaxis: 75 mg taken once daily for at least 10 days following exposure, or up to 6 weeks during a community outbreak.
- Administration: Can be taken with or without food. However, taking it with a light meal is highly recommended to drastically reduce the severe nausea and vomiting frequently caused by the medication.
- Renal Impairment: The dose must be significantly reduced (e.g., 30 mg) or dosing intervals extended in patients with moderate to severe renal impairment (creatinine clearance < 60 mL/min).
Safety Warnings (CRITICAL Regulatory & Clinical Data):
- Neuropsychiatric Events (BLACK BOX EQUIVALENT): Patients (particularly pediatric and adolescent patients) with influenza receiving Oseltamivir have reported severe neuropsychiatric events, including self-injury, delirium, hallucinations, and abnormal behavior. Patients must be closely monitored for signs of abnormal behavior throughout the treatment period.
- Severe Gastrointestinal Distress: Nausea and vomiting are the most common side effects, sometimes severe enough to cause patients to discontinue the medication. Taking the capsule with food mitigates this risk.
- Severe Skin Reactions: Rare cases of anaphylaxis and serious skin reactions, including Toxic Epidermal Necrolysis (TEN) and Stevens-Johnson Syndrome (SJS), have been reported. Stop treatment immediately if a severe rash develops.
Global Export & Contract Manufacturing Services
Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and NGO Health Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Antiviral Formulations, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable Government Tender Supplier for pandemic stockpiling in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Bulk Indenting, ensuring that every Authorized Medicine Wholesaler receives WHO-GMP certified products at competitive rates.









Reviews
There are no reviews yet.